China Regulator Fines Two Pharma Firms for Monopoly Behaviour

China Regulator Fines Two Pharma Firms for Monopoly Behaviour
Photo: unsplash.com 28.05.2023 632

On May 28, China's market regulator said on Sunday it had fined two pharmaceutical companies for monopolistic behaviour.

It fined Grand Pharmaceutical 136 million yuan ($19.68 million) and confiscated 149 million yuan of "illegal revenue" for entering into a monopolistic deal with Wuhan Healcare Pharmaceuticals.

The regulator fined Wuhan Healcare Pharmaceuticals 4.13 million yuan and confiscated slightly over 30 million yuan of its revenue.

Source: Reuters

pharmaceutical markets  China 

Share with friends

Related content